SKping cell cycle regulation: role of ubiquitin ligase SKP2 in hematological malignancies.
Saved in:
| Title: | SKping cell cycle regulation: role of ubiquitin ligase SKP2 in hematological malignancies. |
|---|---|
| Authors: | William JNG; Department of Medical, Oral and Biotechnological Sciences (DSMOB), Ageing Research Center and Translational Medicine-CeSI-MeT, 'G. d'Annunzio' University Chieti-Pescara, Chieti, Italy., Dhar R; Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India., Gundamaraju R; ER Stress and Intestinal Mucosal Biology Lab, School of Health Sciences, University of Tasmania, Launceston, TAS, Australia., Sahoo OS; Department of Biotechnology, National Institute of Technology, Durgapur, India., Pethusamy K; Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India., Raj AFPAM; Institute of Environmental Protection and Sensors (IOS), Maribor, Slovenia., Ramasamy S; Cardiac Metabolic Disease Laboratory, Department Of Biochemistry, School of Biological Sciences, Madurai Kamaraj University, Madurai, India., Alqahtani MS; Radiological Sciences Department, College of Applied Medical Sciences, King Khalid University, Abha, Saudi Arabia.; BioImaging Unit, Space Research Centre, University of Leicester, Leicester, United Kingdom., Abbas M; Electrical Engineering Department, College of Engineering, King Khalid University, Abha, Saudi Arabia., Karmakar S; Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India. |
| Source: | Frontiers in oncology [Front Oncol] 2024 Mar 15; Vol. 14, pp. 1288501. Date of Electronic Publication: 2024 Mar 15 (Print Publication: 2024). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
